Print

US FDA Panel Rejects Forest Laboratories, Inc. (FRX), Nycomed Lung Drug  
4/8/2010 6:57:28 AM

Reuters -- Forest Laboratories Inc suffered a setback on Wednesday as a U.S. advisory panel voted against recommending approval of an experimental drug to treat a common and deadly lung disorder.
//-->